IDH1 MUTATIONS IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES ARE ASSOCIATED WITH AN UNFAVORABLE PROGNOSIS

被引:0
|
作者
Thol, F. [1 ]
Weissinger, E. [1 ]
Krauter, J. [1 ]
Wagner, K. [1 ]
Damm, F. [1 ]
Wichmann, M. [1 ]
Goehring, G. [1 ]
Schumann, C. [2 ]
Bug, G. [3 ]
Ottmann, O. [3 ]
Hofmann, W. K. [2 ]
Schlegelberger, B. [1 ]
Ganser, A. [1 ]
Heuser, M. [1 ]
机构
[1] MHH, Hannover, Germany
[2] Univ Hosp Mannheim, Mannheim, Germany
[3] Goethe Univ Frankfurt, Frankfurt, Germany
来源
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2010年 / 95卷
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
0318
引用
收藏
页码:128 / 128
页数:1
相关论文
共 50 条
  • [1] IDH1 mutations in patients with myelodysplastic syndromes are associated with an unfavorable prognosis
    Thol, Felicitas
    Weissinger, Eva M.
    Krauter, Juergen
    Wagner, Katharina
    Damm, Frederik
    Wichmann, Martin
    Goehring, Gudrun
    Schumann, Christiane
    Bug, Gesine
    Ottmann, Oliver
    Hofmann, Wolf-Karsten
    Schlegelberger, Brigitte
    Ganser, Arnold
    Heuser, Michael
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 (10): : 1668 - 1674
  • [2] IDH1 and IDH2 mutations in myelodysplastic syndromes and role in disease progression
    C D DiNardo
    E Jabbour
    F Ravandi
    K Takahashi
    N Daver
    M Routbort
    K P Patel
    M Brandt
    S Pierce
    H Kantarjian
    G Garcia-Manero
    Leukemia, 2016, 30 : 980 - 984
  • [3] IDH1 and IDH2 mutations in myelodysplastic syndromes and role in disease progression
    DiNardo, C. D.
    Jabbour, E.
    Ravandi, F.
    Takahashi, K.
    Daver, N.
    Routbort, M.
    Patel, K. P.
    Brandt, M.
    Pierce, S.
    Kantarjian, H.
    Garcia-Manero, G.
    LEUKEMIA, 2016, 30 (04) : 980 - 984
  • [4] IDH1 Mutation Is an Independent Inferior Prognostic Indicator for Patients with Myelodysplastic Syndromes
    Wang, Na
    Wang, Fei
    Shan, Ningning
    Sui, Xiaohui
    Xu, Hongzhi
    ACTA HAEMATOLOGICA, 2017, 138 (03) : 143 - 151
  • [5] Differential prognostic effect of IDH1 versus IDH2 mutations in myelodysplastic syndromes: a Mayo Clinic Study of 277 patients
    M M Patnaik
    C A Hanson
    J M Hodnefield
    T L Lasho
    C M Finke
    R A Knudson
    R P Ketterling
    A Pardanani
    A Tefferi
    Leukemia, 2012, 26 : 101 - 105
  • [6] Differential Prognostic Effect of IDH1 Versus IDH2 Mutations in Myelodysplastic Syndromes: A Mayo Clinic Study of 277 Patients
    Patnaik, Mrinal M.
    Hanson, Curtis A.
    Hodnefield, Janice M.
    Lasho, Terra L.
    Finke, Christy
    Knudson, Ryan A.
    Ketterling, Rhett P.
    Pardanani, Animesh
    Tefferi, Ayalew
    BLOOD, 2011, 118 (21) : 444 - 444
  • [7] Differential prognostic effect of IDH1 versus IDH2 mutations in myelodysplastic syndromes: a Mayo Clinic Study of 277 patients
    Patnaik, M. M.
    Hanson, C. A.
    Hodnefield, J. M.
    Lasho, T. L.
    Finke, C. M.
    Knudson, R. A.
    Ketterling, R. P.
    Pardanani, A.
    Tefferi, A.
    LEUKEMIA, 2012, 26 (01) : 101 - 105
  • [8] Clonal leukemic evolution in myelodysplastic syndromes with TET2 and IDH1/2 mutations
    Lin, Tung-Liang
    Nagata, Yasunobu
    Kao, Hsiao-Wen
    Sanada, Masashi
    Okuno, Yusuke
    Huang, Chein-Fuang
    Liang, Der-Cherng
    Kuo, Ming-Chung
    Lai, Chang-Liang
    Lee, En-Hui
    Shih, Yu-Shu
    Tanaka, Hiroko
    Shiraishi, Yuichi
    Chiba, Kenichi
    Lin, Tung-Huei
    Wu, Jin-Hou
    Miyano, Satoru
    Ogawa, Seishi
    Shih, Lee-Yung
    HAEMATOLOGICA, 2014, 99 (01) : 28 - 36
  • [9] A nonsense mutation of IDH1 in myelodysplastic syndromes and related disorders
    K Yoshida
    M Sanada
    M Kato
    R Kawahata
    A Matsubara
    J Takita
    L-Y Shih
    H Mori
    H P Koeffler
    S Ogawa
    Leukemia, 2011, 25 : 184 - 186
  • [10] A nonsense mutation of IDH1 in myelodysplastic syndromes and related disorders
    Yoshida, K.
    Sanada, M.
    Kato, M.
    Kawahata, R.
    Matsubara, A.
    Takita, J.
    Shih, L-Y
    Mori, H.
    Koeffler, H. P.
    Ogawa, S.
    LEUKEMIA, 2011, 25 (01) : 184 - 186